NASDAQ: IART
Integra Lifesciences Holdings Corp Earnings Dates, Reports, Calls

Integra Lifesciences Holdings earnings were $13.0M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. The latest IART earnings report on Sep 30, 2026 announced Q3 2026 earnings of $14.9M, up 231.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IART reported annual earnings of -$516.5M, with 7,337.7% growth.

IART past earnings growth

How has IART's earnings growth performed historically?

Company
N/A
Industry
-7.1%
Market
93.64%
IART's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IART's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance

IART earnings history

Current Revenue
$1.7B
Current Earnings
$13.0M
Current Profit Margin
0.8%
IART's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IART Return on Equity

Current Company
1.2%
Current Industry
14.1%
Current Market
39.9%
IART's Return on Equity (1.2%)... subscribe to Premium to read more.
High Return on Equity Performance

IART Return on Assets

Current Company
0.4%
Current Industry
6.7%
IART is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IART announces earnings.

IART Return on Capital Employed

Current Company
3.6%
Current Industry
12.9%
IART's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IART vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IART$268.38M$13.01M-41.82%$0.17
SIBN-$5.72M-$14.63MN/A-$0.34
LMRIN/AN/AN/AN/A
IRMD$32.77M$23.98M+30.99%$1.89
CBLL-$63.09M-$66.00MN/A-$1.76

Integra Lifesciences Holdings Earnings Reports & History FAQ

What were Integra Lifesciences Holdings's earnings last quarter?

On IART's earnings call on Oct 21, 2026, Integra Lifesciences Holdings (NASDAQ: IART) reported Q3 2026 earnings per share (EPS) of $0.19, up 371.43% year over year. Total IART earnings for the quarter were $14.85 million. In the same quarter last year, Integra Lifesciences Holdings's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Integra Lifesciences Holdings stock.

Is Integra Lifesciences Holdings profitable or losing money?

As of the last Integra Lifesciences Holdings earnings report, Integra Lifesciences Holdings is currently profitable. Integra Lifesciences Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $13.01 million, a 102.63% decrease year over year.

What was IART's earnings growth in the past year?

As of Integra Lifesciences Holdings's earnings date in Oct 21, 2026, Integra Lifesciences Holdings's earnings has grown year over year. IART earnings in the past year totalled $13.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.